Journal of Clinical and Experimental Investigations

• Yee MS, Pavitt DV, Tan T, Venkatesan S, Godsland IF, Richmond W, et al. Lipoprotein separation in a novel iodixanol density gradient, for composition, density, and phenotype analysis. J Lipid Res. 2008;49:1364-71. doi: 10.1194/jlr.D700044-JLR200.
• Austin MA. Small, dense low-density-lipoprotein as a risk factor for coronary heart-disease. Int J Clin Lab Res. 1994;24:187-92. doi: 10.1007/BF02592460.
• Akyol S, Lu J, Akyol O, Akcay F, Armutcu F, Ke LY, et al. The role of electronegative low-density lipoprotein in cardiovascular diseases and its therapeutic implications. Trends Cardiovasc Med. 2017;27(4):239-46. doi: 10.1016/j.tcm.2016.11.002.
• Sanchez-Quesada JL, Benitez S, Ordonez-Llanos J. Electronegative low-density lipoprotein. Curr Opin Lipidol. 2004;15(3):329-35. doi: 10.1097/00041433-200406000-00014.
• Bancells C, Villegas S, Blanco FJ, Benitez S, Gallego I, Beloki L, et al. Aggregated electronegative low density lipoprotein in human plasma shows a high tendency toward phospholipolysis and particle fusion. J Biol Chem. 2010;285(42):32425-35. doi: 10.1074/jbc.M110.139691.
• Akyol O, Chowdhury I, Akyol HR, Tessier K, Vural H, Akyol S. Why are cardiovascular diseases more common among mood disorders and schizophrenia? The potential involvement of electronegative low-density lipoprotein (LDL) L5. Med Hypotheses 2020;142:109821. doi: 10.1016/j.mehy.2020.109821.
• Fan J, Wang H, Ye G, Cao X, Xu X, Tan W, et al. Low-density lipoprotein is a potential predictor of poor prognosis in patients with coronavirus disease 2019. Metabolism 2020;107:154243. doi: 10.1016/j.metabol.2020.154243.
• Khosravi M, Hosseini-Fard R, Najafi M. Circulating low density lipoprotein. Horm Mol Biol Clin Investig. 2018;35(2). doi: 10.1515/hmbci-2018-0024.
• Rivas-Urbina A, Rull A, Ordonez-Llanos J, Sánchez-Quesada JL. Electronegative LDL: An active player in atherogenesis or a by-product of atherosclerosis? Curr Med Chem. 2019;26(9):1665-79. doi: 10.2174/0929867325666180330093953
• Cao X, Yin R, Albrecht H, Fan D, Tan W. Cholesterol: A new game player accelerating endothelial injuries caused by SARS-CoV-2? Am J Physiol Endocrinol Metab. 2020. doi: 10.1152/ajpendo.00255.2020.
• Sorokin VA, Karathanasis SK, Yang ZH, Freeman L, Kotani K, Remaley AT. COVID-19-associated dyslipidemia: Implications for mechanism of impaired resolution and novel therapeutic approaches. FASEB J. 2020 Jun 26. doi: 10.1096/fj.202001451.

Vancouver

Akyol S, Armutcu F. Electronegative Low-density Lipoprotein (L5) may be Associated with the Severity of COVID-19. J Clin Exp Invest. 2020;11(4):em00756. https://doi.org/10.29333/jcei/8565

APA

Akyol, S., & Armutcu, F. (2020). Electronegative Low-density Lipoprotein (L5) may be Associated with the Severity of COVID-19. Journal of Clinical and Experimental Investigations, 11(4), em00756. https://doi.org/10.29333/jcei/8565

AMA

Akyol S, Armutcu F. Electronegative Low-density Lipoprotein (L5) may be Associated with the Severity of COVID-19. J Clin Exp Invest. 2020;11(4), em00756. https://doi.org/10.29333/jcei/8565

Chicago

Akyol, Suheyla, and Ferah Armutcu. "Electronegative Low-density Lipoprotein (L5) may be Associated with the Severity of COVID-19". Journal of Clinical and Experimental Investigations 2020 11 no. 4 (2020): em00756. https://doi.org/10.29333/jcei/8565

Harvard

Akyol, S., and Armutcu, F. (2020). Electronegative Low-density Lipoprotein (L5) may be Associated with the Severity of COVID-19. Journal of Clinical and Experimental Investigations, 11(4), em00756. https://doi.org/10.29333/jcei/8565

MLA

Akyol, Suheyla et al. "Electronegative Low-density Lipoprotein (L5) may be Associated with the Severity of COVID-19". Journal of Clinical and Experimental Investigations, vol. 11, no. 4, 2020, em00756. https://doi.org/10.29333/jcei/8565